On Christmas day in 2001, Sam Waksal learned that the FDA was rejecting ImClone Systems' application for the cancer drug ...
Artwork: Elena Lokshina, www.artblues.com John Mendelsohn had reached the pinnacle of his scientific career when he was called before US congressional investigators this autumn to answer questions ...
Last year, Yeda Research and Development, the tech transfer office of the Weizmann Institute, sued ImClone and Sanofi-Aventis over the Erbitux patent. (The patent was owned by the latter and licensed ...